Internal Medicine, Gastroenterology · Denver, CO
NPI
1669423430
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2535 S Downing St Ste 380
Denver, CO, 80210
Phone (303) 778-5797
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
187 services
Medicare patients, 2024
114
Average age 68
Drug cost, 2024
$599K
692 prescriptions
Company payments, 2025
$1,245
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clark C Kulig was code 99215 (office e&m - established), 38 times for 31 patients. In total Clark C Kulig billed 187 services in 10 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 38 | 31 | $111.08 | $4,221 |
| 99214 Office E&M - Established | Facility | 37 | 31 | $68.63 | $2,539 |
| 99205 Office E&M - New | Facility | 25 | 25 | $122.66 | $3,066 |
| 99205 Office E&M - New | Office | 13 | 13 | $172.55 | $2,243 |
By year: 2022 $27K for 284 services; 2023 $21K for 216 services; 2024 $19K for 187 services.
Medicare prescription drug claims, 2024
In 2024, the drug Clark C Kulig prescribed most often to Medicare patients was Spironolactone, with 68 prescriptions and refills. In total Clark C Kulig wrote 692 Medicare prescriptions that cost $599K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 68 | 120 | 20 | $646 |
| Furosemide Generic | 67 | 131 | 20 | $342 |
| Ursodiol Generic | 65 | 103 | 16 | $7,049 |
| Lactulose Generic | 53 | 72 | 21 | $2,242 |
| Pantoprazole Sodium Generic | 41 | 79 | 11 | $332 |
| Xifaxan Rifaximin | 40 | 41 | Under 11 | $141K |
| Tacrolimus Generic | 39 | 63 | Under 11 | $3,752 |
| Mycophenolate Mofetil Generic | 29 | 39 | Under 11 | $1,627 |
| Amiloride Hcl Generic | 27 | 39 | Under 11 | $587 |
| Entecavir Generic | 19 | 35 | Under 11 | $3,933 |
| Atorvastatin Calcium Generic | 16 | 25 | Under 11 | $63.76 |
| Midodrine Hcl Generic | 15 | 18 | Under 11 | $558 |
| Neomycin Sulfate Generic | 15 | 21 | Under 11 | $1,906 |
| Cefdinir Generic | 14 | 21 | Under 11 | $913 |
| Epclusa Sofosbuvir/Velpatasvir | 13 | 13 | Under 11 | $316K |
Brand drugs: 119 claims; generic drugs: 573 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clark C Kulig $1,245 ($1,245 in general payments such as food, travel and fees) from 15 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $335.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 9 | $335 |
| Medtronic, Inc. MDT | 2 | $173 |
| Orphalan Inc | 1 | $150 |
| Mallinckrodt Hospital Products Inc. | 2 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $142 |
| Madrigal Pharmaceuticals MDGL | 2 | $63.66 |
| Abbvie Inc. ABBV | 2 | $37.76 |
| Novo Nordisk Inc NVO | 1 | $34.59 |
| Lilly USA, LLC LLY | 1 | $33.29 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $27.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.